To determine the organ distribution of production of the three endothelin (ET) isopeptides, we have developed three ribonuclease protection assays specific for the messenger RNAs (mRNAs) of rat ETs 1, 2, and 3.12 organs from adult Sprague-Dawley rats were examined: heart, lung, liver, spleen, kidney, stomach, small intestine, large intestine, testis, muscle, salivary gland, and brain. The mRNA for ET1 was five times more abundant in the lung than in any other organ studied, moderate expression was seen in the large intestine, and lower levels of mRNA were detected in each of the other organs examined. ET2 was expressed at high level in both large and small intestine and at low level in stomach, muscle, and heart, but ET2 mRNA could not be detected elsewhere. ET3 mRNA was found in all organs, particularly in small intestine, lung, kidney, and large intestine. Because of reports suggesting that ETs might be involved in the hypoperfusion and hypofiltration observed in postischemic kidneys, we have also studied levels of mRNA in kidneys that had previously been subjected to 25 or 45 min of clamping of the renal pedicle. At 6 h after 45 min of ischemia, ET1 mRNA increased to a peak of 421 +/-69% (mean +/-SEM, n = 3) of that in a standard renal RNA preparation. 
Introduction
The endothelins (ETs)' are a family of three 21-amino acid peptides that are both potent vasoconstrictors and have mitogenic properties (1) (2) (3) . The power of these effects suggests im-portant physiological or pathophysiological action, but their functions remain elusive. The concentrations of mature peptides within the circulation are usually lower than those reported to have biological activity (4) . This, coupled with the demonstration of similar localizations of ET mRNA and ET binding sites in various organs (5) , has led to the suggestion that the ET system functions largely in an autocrine or paracrine manner (5) . Estimates of tissue concentrations of ET have been reported (6) (7) (8) . However, such studies suffer from the problem that currently available radioimmunoassays are not capable ofdistinguishing between ETs 1 and 2, which differ by only two or three amino acids (depending on species).
Production of ETs appears to be regulated predominantly through modulation of mRNA levels ( 1 ). Thus it is likely that measurement of such levels would reflect endothelin activity. RNAase protection techniques have therefore been developed which are capable ofdiscerning between the mRNAs ofeach of the three rat ETs. This method is considerably more sensitive than Northern blotting and, because more than a single basepair mismatch between probe and template leads to failure of hybridization (9) , has the specificity to distinguish between ETs 1, 2, and 3. The tissue distributions ofthe three endothelin mRNAs are reported, as are the effects of unilateral renal ischemia on renal levels of mRNAs encoding for the three isopeptides.
Methods
Cloning offragments ofthe three rat ETgenes. A combination of PCR and library screening techniques were used to clone genomic fragments of the genes for rat ETs 1, 2, and 3. Further subcloning procedures served to generate smaller fragments optimal for the production of labeled antisense RNA transcripts appropriate for use in RNAase protection assays. In each case these included the coding sequence for a substantial fragment ofthe mature ET peptide, with adjacent 5' intron. ET]. A two-stage polymerase chain reaction (PCR) technique was used: this involved partially nested primers designed from human sequence information ( 10) and 1 ,g of rat genomic DNA as initial template. The first stage (primers: sense GGCTTGCCAAGGAGCTCC, oligo 1; antisense ACTCGGGAGTGTTGACCC, oligo 2) was conducted in buffer containing 7-deaza-2-deoxy GTP 150 ,mol/liter and dGTP 50 Amol /liter, all other nucleotides being present at a concentration of 200 Mmol/ liter. After initial denaturation at 94'C for 4 After homogenization, 0.5 g N-lauroylsarcosine and 3 ml ofcesium chloride (0.96 g/ml) were added to each 6.5-ml aliquot of homogenate, the sarcosine was dissolved by vigorous vortexing, and the solution was layered on top ofa 4-ml cesium chloride cushion. The samples were centrifuged at 32,000 rpm at 20°C for 22 h in an ultracentrifuge (Beckman Instruments Inc, Palo Alto, CA). After centrifugation, the supernatant was removed, the RNA pellet was dissolved in 350 ,l of 10 mM Tris, pH 7.5, 1 mM EDTA buffer with 0.2% SDS, and the RNA was precipitated with the addition of 35 gl of 3 M sodium acetate, pH 5.5, and 2.5 vol of absolute alcohol. RNA samples were stored at -70°C before analysis.
Study ofeffects ofrenal ischemia. Experiments were performed on male Sprague-Dawley rats weighing 250-320 g. Under anesthesia (pentobarbital 60 mg/kg) the left kidney was exposed through a flank incision and the renal pedicle totally occluded for 25 or 45 min by the application of an atraumatic vascular clamp. The clamp was then removed and surgical repair effected. Both right and left kidneys were removed 2, 6, and 24 h and 2 and 7 d later and RNA was extracted as described above (n = 3 each group).
RNAase protection assay. Continuously labeled antisense RNA transcripts to ETs 1, 2, and 3 were generated by in vitro transcription using SP6 polymerase (Amersham International) and [a-32P]GTP (410 Ci/mmol, Amersham International). The same technique was also used to produce a probe that protected a 97-bp fragment ofhuman a-globin mRNA using a template construct extending from position -102 in the a promoter to the BssH I site in exon 1 of the human a-globin gene. Preliminary experiments revealed that the rat ET probes did not protect any fragment of K562 RNA and the a globin probe did not cross-react with rat RNA. To ensure equivalent specific activity all hybridizations of samples run on a single gel were performed by using probes made from the same batch of [a-32P]GTP.
For analysis of mRNA, the precipitated total RNA was dissolved in an aliquot of hybridization buffer (80% formamide, 40 mM Pipes, 400 mM sodium chloride, 1 mM EDTA, pH 8) and the RNA concentration determined by absorbance measurements at 260 nm using a DU-62 spectrophotometer (Beckman Instruments, Inc.). The concentrations were adjusted to yield 50-Ml samples containing 100 ,g of RNA, except in the case of assay of ET I abundance in lung, where the quantity of RNA was reduced to 25 jig. Hybridization was performed overnight at 600C with 5 x 105 cpm of the appropriate ET probe and 5 x I0 5 cpm of a-globin probe. RNAase digestion was then carried out at 37°C for 30 min, and terminated by the addition of 60 Ml ofproteinase K (1 mg/ml) with 3% SDS and further incubation at 37°C for 30 min. Phenol-chloroform and then chloroform extractions were performed and the RNA fragments precipitated with 2.5 vol of absolute alcohol.
The precipitated RNA was subsequently dissolved in 5 ,d of 80% formamide running buffer, and the reaction mix electrophoresed on a denaturing 10% polyacrylamide gel.
After electrophoresis the gels were dried and subjected to autoradiography at -70°C, after which the autoradiographs were aligned with their corresponding gels and the protected ET and a-globin mRNA bands excised. These were then counted using a flat-bed liquid scintillation counter (model 1205 Beta Plate, Pharmacia-Wallac OY, Turkey, Finland) with a method which has been demonstrated to produce a linear response across the range of activities assayed in these experiments ( 14) .
In the study of organ distribution the abundance of ET mRNA in each organ was described as a percentage ofthe quantity determined in a standard RNA 100 Mg large intestine, 2 Mg K562 RNA. Linear regression analyses were used to describe the relationships between counts per minute of protected a-globin and ET bands and the amounts of each standard loaded. The regression formulas obtained were then used to derive estimates of the quantity of a-globin and ET mRNA present in each experimental sample. The efficiency of recovery of mRNA in each sample was estimated from the percent recovery of a-globin. The quantity of ET mRNA was expressed as a percentage of that found in the standard RNA preparations.
In the study of renal ischemia the abundance of ET mRNA was expressed in relation to that present in a preparation of RNA from pooled rat kidneys. took the same form as that described for the study of organ distribution. Statistical comparison between each group of experimental kidneys and standard was made using an unpaired t test. A two-sided P value of < 0.05 was taken as indicating significance.
Results
Partial nucleotide sequences of the genomic rat ET probes are shown in Fig. 1 . The 63 nucleotide segment encoding the 21 amino acids of the mature rat ET 1 peptide differs at five positions from its human counterpart, but these differences do not affect the predicted amino acid sequence. The location of a consensus splice site sequence (15) 154 bp from the 3' end of the riboprobe predicts a protected fragment of the size observed. The position of this consensus sequence is also the point at which homology with human ET1 genomic sequence (10) is lost. The rat ET2 probe contains 155 bp of exonic sequence identical to that reported by Bloch et al. ( 11) . In this region there is considerable homology with human ET2 cDNA sequence ( 11) . Adjacent is a consensus splice site sequence, 5' to which homology with the human cDNA is lost. A protected ET2 fragment of 155 bp was observed. The rat ET3 probe contains sequence identical to that reported by Yanagisawa et al. ( 16) and reveals a potential splice site 140 bp from the 3' Acc I site. A protected fragment of this length was obtained.
To test the specificity of the ET probes (ET1 vs. ET2 vs. ET3), the three riboprobe vectors were each linearized by cleavage at a unique polylinker site at the 3' end of the ET insert. Sense RNA transcripts ofgenomic DNA encoding for each ET isoform were then generated by in vitro transcription using T7 RNA polymerase (Boehringer Mannheim GmbH, Mannheim, FRG). The reaction, performed under conditions recommended by the manufacturer, was allowed to proceed for 30 min, after which DNA template was removed by digestion with DNAase I. RNA was recovered by precipitation with sodium acetate/alcohol and dissolved in hybridization buffer.
I / 1 0,000th of the total yield of each product was then hybridized and processed (in separate reactions) with each ET probe, as described in Methods. Fig. 2 ferred full-length protection on the ETl probe (as expected), but no protected bands (other than at < 26 bp in length) could be seen using the ET2 or ET3 probes. In a similar manner, the ET2 sense RNA transcript protected the ET2 probe, but failed to protect either the ETl or ET3 probes, and the ET3 sense RNA transcript protected the ET3 probe, but neither the ET I nor ET2 probes. These findings strongly support the contention that the ET probes are highly specific for their own isoform of ET. Organ distribution ofthe three ETmRNAs. Fig. 3 shows the organ distribution of mRNA for ETl. Protected bands of the expected length ( 154 bp) can be seen. These are most intense in samples from lung and large intestine. Also seen are two other protected fragments. The smaller, running at 97 bp, represents hybridization of a-globin probe with a-globin mRNA. The larger, running at 242 bp, is due to full-length hybridization with probe ET I sequence. The probe itself is 272 bp, the additional 30 bp owing to the inclusion of polylinker. The band representing full-length protection could be due to hybridization of probe either with contaminating rat DNA or with unspliced RNA transcript. However, a number of considerations make it almost certain that the latter is correct. Firstly, the intensity ofthe larger band is always proportional to the intensity of the spliced mRNA protected fragment. Secondly, probing ofthe same RNA samples with the ET3 probe fails to show any evidence of full-length protection (see Fig. 5 below) . Table  I shows estimation of the efficiency of RNA recovery and quantitation of ETl mRNA in each organ. It can be seen that ET 1 mRNA was much more abundant in the lung than elsewhere. Variation in efficiency of RNA recovery from different organs was small and unlikely to contribute significantly to the large variations in ET 1 mRNA abundance observed. Fig. 4 shows the organ distribution of mRNA for ET2. The picture is clearly distinct from that of ET 1. High levels of expression were obtained in both large and small intestine. Lower levels of expression (apparent on an autoradiograph exposed for 5 d) were seen in heart, muscle, and stomach. Protected bands representing a-globin mRNA and full-length protection of the ET2 probe by unspliced RNA are also seen. Table I shows quantitation of ET2 mRNA in those organs where expression was detected. No attempt was made to quantify ET2 mRNA in organs in which an autoradiograph exposed for 5 d failed to show a visible protected band. Fig. 5 shows the organ distribution of mRNA for ET3. The pattern is different from that of either ET I or ET2, the highest level of expression being seen in small intestine. Between the protected band running at 140 bp, compatible with the length of protected ET3 fragment predicted from the sequence data, and the a-globin protected band, there are a number of other bands. The nature of these bands is uncertain. They were a constant feature of the ET3 protection assay and always present in proportion to the intensity of the 140-bp band. They may represent the formation of secondary structure in the RNA or reflect alternative splicing of the mRNA; indeed two consensus splice site sequences can be seen close together in the sequence data (Fig. 1) . For the purposes of quantitation only the 140-bp band was excised from the gel. renal ischemia. The level of ET1 mRNA rose in the postischemic kidney. 2 h after relief of both 25-and 45-min periods of ischemia, the abundance had increased to over twice that in the pooled rat kidney standard, and 6 h after the longer insult the level had risen to 421±69% of standard. The effect was long- This study demonstrates the expression of ETs 1, 2, and 3 in a variety of adult rat tissues. The organ distribution of mRNAs encoding each of the three isopeptides was distinct. ET1 mRNA was particularly abundant in the lung and moderately expressed in large intestine, and lower levels were detectable in all organs examined. ET2 was expressed at a high level in both large and small intestine; low levels were observed in stomach, muscle, and heart; but ET2 mRNA could not be detected in the other organs studied. Expression of ET3 could be demonstrated in all organs, the abundance of mRNA being more evenly distributed than that of ET l. A number of techniques have previously been used to determine the production of ETs in various organs. These comprise estimates of tissue ET-like immunoreactivity (6-8), Northern blotting ( 1, 2, 5, 11, 12, 16 ), in situ hybridization (5, 17) , and polymerase chain reaction ( 18) .
Tissue Expression ofthe Three Endothelin Genes 1027 The studies of ET-like immunoreactivity report the presence of immunoreactive material in all organs examined, with the exception ofadrenal glands and colon (8) , and with particularly high levels in renal medulla and lung (6) . However, all of these studies suffer from the disadvantage that the antibodies used were incapable of distinguishing between the three ET isoforms.
The The response to renal ischemia demonstrates, for the first time, a situation in which the expression of ET isoforms is clearly regulated in a differential manner: ET1 mRNA increased in the postischemic organ, while ET3 mRNA simultaneously decreased; ET3 mRNA fell transiently in the control kidney, whereas ETI mRNA was unaffected. These findings indicate that ET isoforms are subject to control by distinct regulatory mechanisms they mean that the ETs cannot be considered in a manner that assumes that each isoform behaves in a similar way, and that an inducer or repressor of one will necessarily act likewise upon another. They also imply for immunoassays that cross-react between ETs that an observation ofunchanged ET immunoreactivity does not exclude the possibility of important changes in ET gene expression, with induction of one isoform offset by repression of another.
A final point worthy of note is the longevity ofthe postischemic changes in expression of the ET genes. The mRNA for human ETI is extremely labile, with an apparent intracellular half-life of -15 min (25) . If the same is true of rat ET 1, which would be consistent with the large proportion of primary transcripts observed, then this must imply that the increased levels of ETI mRNA persistently observed after a short-lived period of renal ischemia are due to continuing induction of gene expression. The cause of such induction is not addressed by the present study, but postischemic entry ofcalcium may be a possibility, inasmuch as calcium entry has been reported to induce the expression of ETI (1).
In summary, by using RNAase protection assays specific for each of the ET isoforms, we have demonstrated three distinct patterns oforgan distribution ofgene expression. We have also demonstrated a potential for differential regulation of the ET genes, with renal ETI mRNA increasing and ET3 mRNA decreasing after a temporary period of renal ischemia.
